Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Kushi Kullar who wrote (11266)	8/16/1999 11:48:00 PM
From: dwight martin	Read Replies (1) \| Respond to of 17367

Where the hell does Bloomberg get all this additional info that the XOMA management couldn't be bothered to tell the shareholders at the CC? Boy, am I pissed! If Bloomberg is right, the management at XOMA deserves nothing from the stockholders but hard looks and deep suspicion.

To: Kushi Kullar who wrote (11266)	8/17/1999 12:04:00 AM
From: John Romeo	Respond to of 17367

This is Ellen Martin's quote from the Bloomberg Release. I do not understand how uncertainty is higher. Today we were told Neuprex has "clinical benefit".Now Ellen is stating afterward uncertainty is Higher!! Based on Castello's comments we have more information now than before.That leads to certainty of a future event to take place.This needs clarification. ''The level of uncertainty is higher than it was before,'' said Ellen Martin, a company spokeswoman.